Related Experiment Video
Updated: Sep 6, 2025

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
Published on: January 24, 2020
Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents
Akmal M Asrorov1,2,3, Bahtiyor Muhitdinov1,2, Bin Tu1
1Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Abstract:
Cancer is one of the most serious human diseases, causing millions of deaths worldwide annually, and, therefore, it is one of the most investigated research disciplines. Developing efficient anticancer tools includes studying the effects of different natural enzymes of plant and microbial origin on tumor cells. The development of various smart delivery systems based on enzyme drugs has been conducted for more than two decades. Some of these delivery systems have been developed to the point that they have reached clinical stages, and a few have even found application in selected cancer treatments. Various biological, chemical, and physical approaches have been utilized to enhance their efficiencies by improving their delivery and targeting. In this paper, we review advanced delivery systems for enzyme drugs for use in cancer therapy. Their structure-based functions, mechanisms of action, fused forms with other peptides in terms of targeting and penetration, and other main results from in vivo and clinical studies of these advanced delivery systems are highlighted.
Insights
Advanced enzyme drug delivery systems show promise for cancer therapy. These smart systems, derived from natural enzymes, are improving tumor targeting and treatment efficacy, with some reaching clinical application.
Area of Science:
- Biochemistry
- Oncology
- Biotechnology
Background:
- Cancer remains a leading global cause of mortality, driving extensive research into novel therapeutic strategies.
- Natural enzymes from plant and microbial sources are being explored for their anticancer potential.
- Smart delivery systems for enzyme drugs have been developed over two decades, with some progressing to clinical trials.
Purpose of the Study:
- To review advanced delivery systems for enzyme drugs in cancer therapy.
- To highlight structure-function relationships, mechanisms of action, and targeting strategies.
- To summarize in vivo and clinical study outcomes of these systems.
Main Methods:
- Review of existing literature on enzyme drug delivery systems for cancer.
- Analysis of structure-based functions and mechanisms of action.
- Evaluation of fused forms with targeting peptides and clinical study results.
Main Results:
- Advanced delivery systems enhance enzyme drug efficacy through improved targeting and delivery.
- Various biological, chemical, and physical approaches are employed to optimize these systems.
- Several enzyme-based delivery systems have reached clinical stages for cancer treatment.
Conclusions:
- Advanced enzyme drug delivery systems represent a significant development in cancer therapy.
- These systems offer enhanced targeting and penetration, improving treatment outcomes.
- Continued research and clinical studies are crucial for realizing the full potential of enzyme-based cancer treatments.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

